Dynabeads™ M-280 Sheep anti-Mouse IgG는 bead 표면에 친화성 정제 다클론 sheep anti-mouse IgG가 공유결합된 2.8 μm superparamagnetic bead입니다. 이들 bead는 mouse IgG와 표적 단백질이 간단하고 효율적으로 결합하게 도와주는 고형 보조제입니다. 이 다클론 sheep 항체는 mouse IgG1, IgG2a, IgG2b에 모두 결합하고 mouse IgG3 및 IgM에 대한 반응성은 낮습니다. 인간 교차 반응성이 최소 수준입니다.
• 빠르고 쉬운 결합 및 분리 절차 • 컬럼 또는 원심분리 단계가 필요하지 않습니다. • 대부분의 mouse IgG subclass에 결합합니다.
자기 bead 기반 분리로 취급이 쉽습니다. 표적 분자를 인식하는 일차 항체를 샘플에 추가하거나(간접법) Dynabeads™ M-280 Sheep anti-Mouse IgG에 미리 코팅할 수 있습니다(직접법). 어떤 방법을 사용하든 Dynabeads™ M-280 Sheep anti-Mouse IgG를 샘플에 섞으면 bead가 표적에 결합합니다. 샘플을 자석에 놓으면 bead와 결합한 표적이 나머지 샘플에서 분리됩니다. 그렇게 되면 흡인으로 상층액을 제거합니다. 표적 분자는 기존 용출 방법으로 bead에서 용출시키거나 bead에 부착된 채로 downstream 응용연구에 사용할 수 있습니다.
다양한 응용연구에 적용가능 Dynabeads™ M-280 Sheep anti-Mouse IgG는 균일한 구형, 단분산, 비기공성 bead로 Ig, 단백질 정제, sandwich immunoassays, IP, Co-IP, 세포 및 미생물 분리 등의 응용연구에 이상적입니다. 이들은 용액에서 매우 이동성이 높아 포획 표면이 자유롭게 지속적으로 전체 샘플 용량과 상호작용할 수 있습니다. • 전체 응용연구에 대한 Dynabeads™ 제품검색 • Dynabeads™ 분리용 magnet 검색.
For Research Use Only. Not for use in diagnostic procedures.
사양
인증/적합성ISO9001 and ISO13485
색상Brown
농도10 mg/mL
설명Polyclonal sheep anti-mouse IgG covalently bound to Dynabeads
반응성Binds mouse IgG1, IgG2a and IgG2b. Low reactivity towards mouse IgG3 and IgM.
규제 상태For Research Use Only
유통 기한36 months from date of manufacture
배송 조건Ambient temperature
종Sheep
타겟Proteins
균일성Monosized 2.8 μm (CV <5%)
유형Antibody Coated Bead
Unit SizeEach
구성 및 보관
Dynabeads M-280 Sheep Anti-Mouse IgG is supplied in PBS, pH 7.4 w/0.1% BSA, 0.02% NaN3 Store at 2°C to 8°C.
자주 묻는 질문(FAQ)
I am getting high background using Dynabeads M-280 Streptavidin magnetic beads. How can I prevent this from happening?
The background might be caused by nonspecific binding to the BSA on the bead surface. Alternatively, high background might be caused by nonspecific binding to streptavidin. Increasing either the pH or the salt concentration might help reduce the binding. Dynabeads M-270 Streptavidin magnetic beads might be a better alternative; these beads are not coated with BSA and are hydrophilic, as they are based upon carboxylic acid chemistry.
My Dynabeads magnetic beads are not pelleting well with the magnet. Do you have any suggestions for me?
Please review the following possibilities for why your Dynabeads magnetic beads are not pelleting:
- The solution is too viscous.
- The beads have formed aggregates because of protein-protein interaction.
Try these suggestions:
- Increase separation time (leave tub on magnet for 2-5 minutes)
- Add DNase I to the lysate (~0.01 mg/mL)
- Increase the Tween 20 concentration to ~0.05% of the binding and/or washing buffer.
- Add up to 20 mM beta-merecaptoethanol to the binding and/or wash buffers.
I have a long double-stranded DNA fragment I would like to isolate. What product do you recommend?
For biotin-labeled DNA that is less than 1 kb, we recommend you use Dynabeads M270 Streptavidin (Cat. No. 65305) and MyOne C1 magnetic beads (Cat. No. 65001). We recommend our Dynabeads KilobaseBINDER Kit (Cat. No. 60101), which is designed to immobilize long (>1 kb) double-stranded DNA molecules. The KilobaseBINDER reagent consists of M-280 Streptavidin-coupled Dynabeads magnetic beads along with a patented immobilization activator in the binding solution to bind to long, biotinylated DNA molecules for isolation. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/immobilisation-of-long-biotinylated-dna-fragments.html) for more information in regards to long biotinylated DNA fragment isolation.
Can I use Dynabeads magnetic beads to isolate single-stranded DNA templates?
Yes, Dynabeads magnetic beads can be used to isolate single-stranded DNA. Streptavidin Dynabeads magnetic beads can be used to target biotinylated DNA fragments, followed by denaturation of the double-stranded DNA and removal of the non-biotinylated strand. The streptavidin-coupled Dynabeads magnetic beads will not inhibit any enzymatic activity. This enables further handling and manipulation of the bead-bound DNA directly on the solid phase. Please see the following link (https://www.thermofisher.com/us/en/home/life-science/dna-rna-purification-analysis/napamisc/capture-of-biotinylated-targets/preparing-single-stranded-dna-templates.html) for more information in regards to single-stranded DNA capture.
What is the magnetic susceptibility for Dynabeads magnetic beads?
Magnetic susceptibility is a measure of how quickly the beads will migrate to the magnet. This will depend on the iron content and the character of the iron oxide. The magnetic susceptibility given for the Dynabeads magnetic beads is the mass susceptibility, given either as cgs units/g or m^3/kg (the latter being an SI unit). For ferri- and ferromagnetic substances, the magnetic mass susceptibility is dependent upon the magnetic field strength (H), as the magnetization of such substances is not a linear function of H but approaches a saturation value with increasing field. For that reason, the magnetic mass susceptibility of the Dynabeads magnetic beads is determined by a standardized procedure under fixed conditions. The magnetic mass susceptibility given in our catalog is thus the SI unit. Conversion from Gaussian (cgs, emu) units into SI units for magnetic mass susceptibility is achieved by multiplying the Gaussian factor (emu/g or cgs/g) by 4 pi x 10^-3. The resulting unit is also called the rationalized magnetic mass susceptibility, which should be distinguished from the (SI) dimensionless magnetic susceptibility unit. In general, magnetic mass susceptibility is a measure of the force (Fz) influencing an object positioned in a nonhomogenous magnetic field. The magnetic mass susceptibility of the Dynabeads magnetic beads is measured by weighing a sample, and then subjecting the sample to a magnetic field of known strength. The weight (F1) is then measured, and compared to the weight of the sample when the magnetic field is turned off (F0). The susceptibility is then calculated as K x 10^-3 = [(F1-F0) x m x 0.335 x 10^6], where K is the mass susceptibility of the sample of mass m. The susceptibility is then converted to SI units.
Development and mechanism of ?-secretase modulators for Alzheimer's disease.
Authors:Crump CJ, Johnson DS, Li YM
Journal:Biochemistry
PubMed ID:23614767
'?-Secretase is an aspartyl intramembranal protease composed of presenilin, Nicastrin, Aph1, and Pen2 with 19 transmembrane domains. ?-Secretase cleaves the amyloid precursor proteins (APP) to release Aß peptides that likely play a causative role in the pathogenesis of Alzheimer's disease (AD). In addition, ?-secretase cleaves Notch and other type I ... More
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Authors:Kvartsberg H, Portelius E, Andreasson U, Brinkmalm G, Hellwig K, Lelental N, Kornhuber J, Hansson O, Minthon L, Spitzer P, Maler JM, Zetterberg H, Blennow K, Lewczuk P
Journal:
PubMed ID:26136856
'Synaptic dysfunction and degeneration are central events in Alzheimer''s disease (AD) pathophysiology that are thought to occur early in disease progression. Synaptic pathology may be studied by examining protein biomarkers specific for different synaptic elements. We recently showed that the dendritic protein neurogranin (Ng), including the endogenous Ng peptide 48 ... More
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Authors:Portelius E, Lashley T, Westerlund A, Persson R, Fox NC, Blennow K, Revesz T, Zetterberg H
Journal:
PubMed ID:25591542
'Senile plaques in Alzheimer''s disease (AD) are composed of amyloid-ß (Aß), especially N-truncated forms including Aß4-42. These are thought to be neurotoxic. However, individuals may live for decades with biomarker evidence of cerebral ß-amyloidosis (positive amyloid PET imaging and/or low cerebrospinal fluid levels of the 42 amino acid form of ... More
Pyroglutamate amyloid ß (Aß) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease.
Authors:Wittnam JL, Portelius E, Zetterberg H, Gustavsson MK, Schilling S, Koch B, Demuth HU, Blennow K, Wirths O, Bayer TA
Journal:J Biol Chem
PubMed ID:22267726
'Pyroglutamate-modified Aß peptides at amino acid position three (Aß(pE3-42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). Aß(pE3-42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim of the present work was to study the ... More
APP metabolism regulates tau proteostasis in human cerebral cortex neurons.
Authors:Moore S, Evans LD, Andersson T, Portelius E, Smith J, Dias TB, Saurat N, McGlade A, Kirwan P, Blennow K, Hardy J, Zetterberg H, Livesey FJ
Journal:
PubMed ID:25921538
'Accumulation of Aß peptide fragments of the APP protein and neurofibrillary tangles of the microtubule-associated protein tau are the cellular hallmarks of Alzheimer''s disease (AD). To investigate the relationship between APP metabolism and tau protein levels and phosphorylation, we studied human-stem-cell-derived forebrain neurons with genetic forms of AD, all of ... More